Position in LH
as of Jun 30, 2024
· filed Aug 13, 2024
Position Value
$1,931,949,725
New position
Shares Held
9,493,144
first reported quarter
Ownership
11.7%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
1 quarter on record
Voting authority
Sole 93%
Shared 0%
None 7%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2024BlackRock Inc. holds $56,157,981,287 across 41 Diagnostics & Research names. LH ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
29,529,326 | $16,329,717,278 | |
| 2 | DHR |
Danaher Corp /De/
|
50,539,226 | $12,627,225,607 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
9,603,226 | $4,678,691,699 | |
| 4 | A |
Agilent Technologies, Inc.
|
25,264,883 | $3,275,086,774 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
15,234,992 | $3,221,286,698 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
1,859,605 | $2,598,965,342 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
9,493,144 | $1,931,949,725 | |
| 8 | ILMN |
Illumina, Inc.
|
18,073,701 | $1,886,532,900 |
All Filings in LH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2024-06-30 | $1,931,949,725 | 9,493,144 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||